CAD 0.01
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2022 | 477.47 Thousand USD | -36.21% |
2021 | 748.48 Thousand USD | 5.42% |
2020 | 709.99 Thousand USD | -19.32% |
2019 | 879.96 Thousand USD | -6.32% |
2018 | 939.37 Thousand USD | -25.59% |
2017 | 1.26 Million USD | -57.06% |
2016 | 2.93 Million USD | -50.0% |
2015 | 5.87 Million USD | 30.77% |
2014 | 4.49 Million USD | 1076.34% |
2013 | 382.2 Thousand USD | 682.49% |
2012 | 48.84 Thousand USD | -99.46% |
2011 | 9.05 Million USD | 1639.21% |
2010 | 520.59 Thousand USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 Q2 | 403.7 Thousand USD | -31.77% |
2023 Q3 | 365.65 Thousand USD | -9.42% |
2023 Q1 | 591.69 Thousand USD | 23.92% |
2022 FY | 477.47 Thousand USD | -36.21% |
2022 Q3 | 522.57 Thousand USD | -8.79% |
2022 Q4 | 477.47 Thousand USD | -8.63% |
2022 Q1 | 661.2 Thousand USD | -11.66% |
2022 Q2 | 572.95 Thousand USD | -13.35% |
2021 Q3 | 943.68 Thousand USD | 52.97% |
2021 Q4 | 748.48 Thousand USD | -20.68% |
2021 Q1 | 692.12 Thousand USD | -2.52% |
2021 FY | 748.48 Thousand USD | 5.42% |
2021 Q2 | 616.88 Thousand USD | -10.87% |
2020 Q3 | 812.39 Thousand USD | -6.02% |
2020 Q1 | 988.96 Thousand USD | 12.39% |
2020 Q2 | 864.38 Thousand USD | -12.6% |
2020 FY | 709.99 Thousand USD | -19.32% |
2020 Q4 | 709.99 Thousand USD | -12.6% |
2019 Q4 | 879.96 Thousand USD | -21.24% |
2019 Q1 | 1.13 Million USD | 20.83% |
2019 Q2 | 1.3 Million USD | 14.87% |
2019 FY | 879.96 Thousand USD | -6.32% |
2019 Q3 | 1.11 Million USD | -14.31% |
2018 Q3 | 1.42 Million USD | -0.33% |
2018 FY | 939.37 Thousand USD | -25.59% |
2018 Q4 | 939.37 Thousand USD | -33.97% |
2018 Q2 | 1.42 Million USD | 8.76% |
2018 Q1 | 1.31 Million USD | 3.97% |
2017 Q2 | 2.68 Million USD | -0.5% |
2017 Q1 | 2.69 Million USD | -8.21% |
2017 FY | 1.26 Million USD | -57.06% |
2017 Q4 | 1.26 Million USD | -51.74% |
2017 Q3 | 2.61 Million USD | -2.58% |
2016 Q4 | 2.93 Million USD | -52.6% |
2016 Q2 | 6.41 Million USD | 1.18% |
2016 FY | 2.93 Million USD | -50.0% |
2016 Q1 | 6.33 Million USD | 7.83% |
2016 Q3 | 6.2 Million USD | -3.32% |
2015 Q4 | 5.87 Million USD | -7.44% |
2015 FY | 5.87 Million USD | 30.77% |
2015 Q2 | 6.07 Million USD | 7.08% |
2015 Q3 | 6.35 Million USD | 4.59% |
2015 Q1 | 5.67 Million USD | 26.15% |
2014 Q2 | 4.17 Million USD | 5.32% |
2014 Q4 | 4.49 Million USD | -17.94% |
2014 Q3 | 5.47 Million USD | 31.18% |
2014 Q1 | 3.96 Million USD | 937.64% |
2014 FY | 4.49 Million USD | 1076.34% |
2013 Q4 | 382.2 Thousand USD | -46.5% |
2013 Q3 | 714.45 Thousand USD | 81.55% |
2013 Q2 | 393.52 Thousand USD | 62.79% |
2013 Q1 | 241.73 Thousand USD | 394.9% |
2013 FY | 382.2 Thousand USD | 682.49% |
2012 FY | 48.84 Thousand USD | -99.46% |
2012 Q1 | 9.55 Million USD | 5.58% |
2012 Q2 | 9.49 Million USD | -0.7% |
2012 Q3 | 9.18 Million USD | -3.24% |
2012 Q4 | 48.84 Thousand USD | -99.47% |
2011 Q3 | 861.02 Thousand USD | 24.48% |
2011 FY | 9.05 Million USD | 1639.21% |
2011 Q4 | 9.05 Million USD | 951.56% |
2011 Q1 | 616.13 Thousand USD | 18.35% |
2011 Q2 | 691.67 Thousand USD | 12.26% |
2010 FY | 520.59 Thousand USD | 0.0% |
2010 Q2 | 1771.42 USD | 0.0% |
2010 Q4 | 520.59 Thousand USD | 23780.9% |
2010 Q3 | 2179.96 USD | 23.06% |
Name | Total Assets | Total Assets Difference |
---|---|---|
AI/ML Innovations Inc. | 329.68 Thousand CAD | -44.826% |
Diagnamed Holdings Corp. | 662.27 Thousand CAD | 27.903% |
Pangenomic Health Inc. | 71.47 Thousand CAD | -568.003% |
nDatalyze Corp. | 877.9 Thousand CAD | 45.612% |
Treatment.Com International Inc. | 739.3 Thousand CAD | 35.416% |
Unidoc Health Corp. | 517.08 Thousand CAD | 7.66% |